Advertisement
Advertisement
VYNE
VYNE Therapeutics Inc. Common Stock
0.65
USDSponsored
0.00
+0.09%
Jun 24, 15:58 UTC -4
Closed
After-Market
0.65
0.00
+0.06%
VYNE Earnings Reports
Positive Surprise Ratio
VYNE beat 22 of 34 last estimates.
65%
Next Report
Date of Next Report
Aug 12, 2026
Estimate for Q2 26 (Revenue/ EPS)
$204.00K
/-$0.18
Implied change from Q1 26 (Revenue/ EPS)
+137.21%
/+125.00%
Implied change from Q2 25 (Revenue/ EPS)
+195.65%
/+38.46%
VYNE Therapeutics Inc. Common Stock earnings per share and revenue
On May 15, 2026, VYNE reported earnings of -0.08 USD per share (EPS) for Q1 26, beating the estimate of -0.18 USD, resulting in a 56.43% surprise. Revenue reached 86.00 thousand, compared to an expected 204.00 thousand, with a -57.84% difference. The market reacted with a +0.94% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 3 analysts forecast an EPS of -0.18 USD, with revenue projected to reach 204.00 thousand USD, implying an increase of 125.00% EPS, and increase of 137.21% in Revenue from the last quarter.
FAQ
What were VYNE Therapeutics Inc. Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, VYNE Therapeutics Inc. Common Stock reported EPS of -$0.08, beating estimates by 56.43%, and revenue of $86.00K, -57.84% below expectations.
How did the market react to VYNE Therapeutics Inc. Common Stock's Q1 2026 earnings?
The stock price moved up 0.94%, changed from $0.67 before the earnings release to $0.68 the day after.
When is VYNE Therapeutics Inc. Common Stock expected to report next?
The next earning report is scheduled for Aug 12, 2026.
What are the forecasts for VYNE Therapeutics Inc. Common Stock's next earnings report?
Based on 3
analysts, VYNE Therapeutics Inc. Common Stock is expected to report EPS of -$0.18 and revenue of $204.00K for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement